Healthcare AI gets tested twice. The first test is the demo: does the model do what it claims, in front of the people who will sign the contract. Almost every AI company in healthcare passes that test now. The second test happens later, quietly, with no one from either vendor or health system in the room to notice: is the AI still running six months after go-live, wired correctly into the EHR, governed against the right compliance rules, owned by someone who will answer for it when a claim gets denied or a member calls in. Only the second test actually matters, and it’s the one most healthcare AI never gets to take, because by month six the champion who bought it has moved roles, the vendor’s implementation team has moved to the next deal, and nobody is left accountable for what happens next.
That is the actual problem this partnership exists to solve, and it’s worth being specific about why it matters at the scale it does. A large health system loses $95 to $180 million a year to denials alone, and more than a third of denied claims are never reworked. Patients hang up on hold by the two-minute mark, well before average hold times even hit four, and the industry leaks an estimated $1 billion in revenue as a result. Nearly two-thirds of prior authorization volume in the US still runs on phone calls, fax machines, and manual entry, right as a new federal rule forces health plans to turn most of it around in 72 hours or 7 days. None of these are technology gaps. They are what’s left standing when AI passes the first test and never gets a fair shot at the second.
Why this partnership is built around the second test, not the first
Innovaccer spent over a decade building the platform that passes the first test decisively: one foundation across clinical, claims, and operational data, with AI agents that do the actual work of revenue cycle, patient access, and payer performance, not just analyze it. At one large health system, that platform cut prior authorization prep time per case from 45 minutes to 3, and it’s still doing that today, not in a pilot that quietly wound down. Results like it are already running across the country, in care management and patient access alike. The first test has been settled for a while now.
Mastek exists to win the second one. Four decades in business, close to 5,000 specialists, a 96% client retention rate, all of it earned by staying in the room after go-live, wiring platforms into real EHRs and real workflows, and remaining the accountable party when something breaks two years into a contract instead of two weeks. That discipline, staying present and answerable long after the deal closes, is not something either of us could manufacture on the other’s timeline. It has to be built the slow way, over decades, one implementation that held up at a time.
Why we’re doing this together, now
Pairing a platform proven at the first test with a partner built for the second is how the thousands of health systems and payer organizations still waiting for AI to actually work get it, not just the handful with the internal teams to survive an implementation on their own. Innovaccer keeps advancing what the platform can do. Mastek keeps it running, accountable, inside every health system, life sciences, public sector and payer organization it touches, for as long as that organization needs it running. Neither of us is interested in doing the other’s job. We are interested in what happens when both jobs get done, together, at the scale this problem actually demands.
What passing the second test looks like
We enable autonomous healthcare operations. That claim is worthless if it only survives the demo. It has to survive month six, month eighteen, the staff turnover, the audit, the Tuesday when a claim gets denied and someone has to already know why. This partnership exists to make sure it does, not for a handful of early movers, but for every health system and payer organization in this country still waiting for AI that stays.
Learn more about this partnership here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
